Leadership Overview
Johnson & Johnson Services Inc has 10 executives leading key functions including strategy, finance, information technology, and marketing.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and surgical products to healthcare providers and patients globally.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and surgical products to healthcare providers and patients globally.
Leadership Roles at Johnson & Johnson Services Inc
Joaquin Duato - Chief Executive Officer
Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the company's overarching strategy and global operations. This leadership position involves guiding the development and delivery of innovative medicines and medical technologies across oncology, immunology, neuroscience, and cardiovascular care. Duato ensures alignment with the company's mission to serve healthcare providers and patients worldwide. The Chief Executive Officer oversees all major business segments, driving growth and market expansion. By fostering a culture of scientific advancement and patient-centricity, Joaquin Duato champions the company's commitment to improving global health outcomes. This role is critical in navigating complex regulatory environments and maintaining Johnson & Johnson's position as a leader in the healthcare industry.

Joseph Wolk - Executive VP & Chief Financial Officer
Joseph Wolk, the Executive VP & Chief Financial Officer at Johnson & Johnson Services Inc, oversees the company's comprehensive financial strategy and operations. This executive leadership role involves managing all aspects of financial planning, reporting, and investment across the global enterprise. Wolk directs capital allocation to support the development of pharmaceuticals and medical technologies, ensuring robust financial health. The Chief Financial Officer ensures compliance with financial regulations and drives shareholder value through disciplined fiscal management. By analyzing market trends and economic conditions, Joseph Wolk guides strategic financial decisions that underpin the company's growth in areas like oncology and immunology. This position is vital for maintaining the financial stability required for Johnson & Johnson Services Inc's extensive research and development efforts.

Jonathan Loane - Chief Financial Officer & Vice President, Medtech Center Finance
Jonathan Loane, the Chief Financial Officer & Vice President, Medtech Center Finance at Johnson & Johnson Services Inc, leads financial operations specifically for the MedTech division. This executive role involves managing the financial health and strategic investments within the medical device sector. Loane oversees budgeting, forecasting, and financial analysis to support the innovation and delivery of surgical products and medical devices. The Vice President, Medtech Center Finance ensures that financial resources are optimally allocated to drive growth and efficiency in this critical business segment. By providing financial oversight, Jonathan Loane supports the development of advanced technologies used in various medical procedures. This leadership ensures the financial viability of MedTech operations, contributing to Johnson & Johnson Services Inc's comprehensive healthcare solutions.
Stephen Tremel - Business Operations Chief Financial Officer & Vice President
Stephen Tremel, the Business Operations Chief Financial Officer & Vice President at Johnson & Johnson Services Inc, manages financial operations and strategic planning for business operations. This executive role focuses on optimizing financial performance and resource allocation across various operational units. Tremel oversees budgeting, financial analysis, and reporting to ensure operational efficiency and cost-effectiveness. The Vice President, Business Operations Chief Financial Officer plays a key part in driving financial discipline and supporting strategic initiatives that enhance productivity. By providing critical financial insights, Stephen Tremel supports the seamless execution of Johnson & Johnson Services Inc's business objectives. This leadership ensures that operational expenditures align with strategic goals, contributing to the company's overall financial health and market position.
Nina Martinez - Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services
Nina Martinez, the Category Director, Innovative Medicine Procurement, Functional Chief Revenue Officer and Clinical Services at Johnson & Johnson Services Inc, manages critical procurement functions for innovative medicines. This role encompasses driving revenue generation through strategic clinical services and optimizing procurement processes. Martinez ensures the efficient acquisition of essential components for pharmaceutical development, directly impacting the availability of treatments for patients. The Functional Chief Revenue Officer aspect of this position involves identifying and capitalizing on new revenue streams within clinical services. Overseeing procurement for innovative medicines, Nina Martinez guarantees supply chain integrity and cost-effectiveness. This leadership ensures that Johnson & Johnson Services Inc can continue to provide cutting-edge medical solutions.
Ko Katsuragi - Manager, Medical Affairs, Chief Marketing Officer Office
Ko Katsuragi, the Manager, Medical Affairs, Chief Marketing Officer Office at Johnson & Johnson Services Inc, supports strategic marketing initiatives within the medical affairs domain. This role focuses on enhancing the communication and dissemination of information regarding innovative medicines and medical technologies. Katsuragi collaborates with the Chief Marketing Officer's office to ensure that medical affairs activities align with broader marketing objectives. The Manager, Medical Affairs contributes to the development of educational materials and programs that support healthcare providers and patients. By bridging medical insights with marketing strategies, Ko Katsuragi helps to effectively position Johnson & Johnson Services Inc's offerings in therapeutic areas such as neuroscience and cardiovascular care. This function is key to translating scientific advancements into market impact.
Jeff Srour - Worldwide Vice President & Chief Information Officer, MedTech
Jeff Srour, the Worldwide Vice President & Chief Information Officer, MedTech at Johnson & Johnson Services Inc, directs the global information technology strategy for the MedTech segment. This leadership position involves overseeing the implementation and management of technology solutions that support the development, manufacturing, and distribution of medical devices and surgical products. Srour ensures that IT infrastructure is robust, secure, and scalable to meet the evolving needs of the MedTech business. The Chief Information Officer drives digital transformation initiatives, enhancing operational efficiency and enabling data-driven decision-making. By leveraging technology, Jeff Srour supports innovation in areas like oncology and immunology, ensuring that MedTech operations are at the forefront of technological advancement. This role is crucial for maintaining competitive advantage and operational excellence.

Dominic Allocco - Vice President and Associate Chief Marketing Officer
Dominic Allocco, the Vice President and Associate Chief Marketing Officer at Johnson & Johnson Services Inc, supports the development and execution of comprehensive marketing strategies. This leadership role involves contributing to brand positioning and market outreach for the company's diverse portfolio of pharmaceuticals and medical technologies. Allocco collaborates with the Chief Marketing Officer to identify market opportunities and enhance customer engagement. The Associate Chief Marketing Officer plays a part in shaping marketing campaigns that effectively communicate the value of innovative medicines and surgical products. By driving strategic marketing efforts, Dominic Allocco helps to strengthen Johnson & Johnson Services Inc's presence in key therapeutic areas. This position is essential for translating product innovation into market success and patient benefit.
Danielle Gomes - Chief Information Officer, J & J Medtech LATAM
Danielle Gomes, the Chief Information Officer, J & J Medtech LATAM at Johnson & Johnson Services Inc, leads information technology initiatives across the Latin American MedTech region. This executive role involves developing and implementing IT strategies to support the growth and operational needs of the MedTech business in LATAM. Gomes oversees the deployment of technology solutions that enhance efficiency, data security, and connectivity for regional operations. The Chief Information Officer ensures that IT infrastructure aligns with global MedTech objectives while addressing specific regional market demands. By driving technological advancements, Danielle Gomes supports the delivery of innovative medical devices and surgical products throughout Latin America. This leadership is critical for maintaining operational excellence and expanding market reach within the region.

Lynn Gorham - Director, Programmatic Chief Revenue Officer
Lynn Gorham, the Director, Programmatic Chief Revenue Officer at Johnson & Johnson Services Inc, focuses on optimizing revenue generation through programmatic strategies. This role involves developing and implementing data-driven approaches to enhance sales performance and market penetration. Gorham directs initiatives aimed at maximizing revenue streams across various business units by leveraging advanced analytics and technology. The Programmatic Chief Revenue Officer ensures that revenue generation efforts are aligned with the company's overall business objectives and market dynamics. By driving efficiency in revenue capture, Lynn Gorham contributes to the financial growth and sustainability of Johnson & Johnson Services Inc. This position is vital for adapting to evolving market landscapes and ensuring competitive revenue performance.
Explore Leadership Teams in Manufacturing
Established in 2009, Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases based upon complement immunotherapy through the inhibition of the complement system at the level of C3. They are based in Waltham, Massachusetts.
Company Leadership TS

KM
Founded in 1971 and headquartered in Hauppauge, New York, Contract Pharmacal (CPC) is a company that manufactures and packages pharmaceuticals, over-the-counter drugs, and dietary supplements for pharmaceutical companies, retailers, and wholesalers worldwide.
Company Leadership

MW
Shionogi & Co., Ltd. is a Japanese pharmaceutical company dedicated to developing innovative treatments that improve patient lives worldwide. With a longstanding focus on addressing pressing global health challenges, the company has been a pioneer in discovering and delivering novel therapies for infectious diseases, including antibiotics, HIV, influenza, and emerging viral threats such as COVID-19. Shionogi combines in-house research and development with strategic collaborations across industry, government agencies, biotech companies, and academic institutions to accelerate the advancement of its scientific programs and bring meaningful therapies to patients with urgency and precision.
Company Leadership
TK
MF
TN
Vanda Pharmaceuticals, founded in 2003, is a biopharmaceutical research and development company focused on creating innovative medicines to improve patient lives. The company leverages advanced technologies including genetics and genomics to guide drug discovery, clinical trials, and commercial strategies. Vanda Pharmaceuticals specializes in developing novel therapeutic approaches and delivery methods for their pharmaceutical products. With operations across North America, Europe, and Asia, the company maintains a global presence in the pharmaceutical industry while continuing to advance medical research and drug development for various health conditions.
Company Leadership BA

PJ
JW